Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9J

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-06-24
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.842, 70.258, 60.577
Unit cell angles90.00, 109.90, 90.00
Refinement procedure
Resolution28.340 - 1.980
R-factor0.162
Rwork0.159
R-free0.21200
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.012
RMSD bond angle1.100
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]28.3402.030
High resolution limit [Å]1.9801.980
Rmeas0.0820.998
Number of reflections254551958
<I/σ(I)>9.6
Completeness [%]94.287.5
Redundancy3.1
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon